The novel tetrahydrofuran derivative ANAVEX2-73 attenuated GSK-3β activation and Tau...
- ANAVEX® Life Sciences Corp.
- Jul 16, 2011
- 1 min read
The novel tetrahydrofuran derivative ANAVEX2-73 attenuated GSK-3β activation and Tau hyperphosphorylation in a nontransgenic Alzheimer’s disease model in mice.
Alzheimer’s Association International Conference, July 16-21, 2011, Paris, France
Valentine Lahmy, Susanna Malmstrom, Johann Meunier, Vanessa Villard, Alexandre Vamvakides and Tangui Maurice